Narrowing patents that claim more than they disclose would open space for rival innovators, not generics
No takes yet. Share an insight, caveat, or question.
Freilich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: